ImmunoTEP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ImmunoTEP, covering 2022-07-26 to 2022-07-26. Get the full timeline:
Most recent: Clinical Trial Update: ImmunoTEP for Patients With Medullary Thyroid Carcinoma. [Phase 1, Phase 2]